Lawsuit Loans Helped Plaintiffs In The Xarelto Lawsuit – Here’s How It Happened
A perfect example of how lawsuit loans can work toward the benefit of plaintiffs can be found in the class-action lawsuit surrounding a drug produced by Johnson & Johnson and Bayer Pharmaceuticals called Xarelto. Xarelto is an anticoagulant drug, and many people who were prescribed this medication alleged that it further complicated their medical issues, or led to death. Although it seemed like a daunting task for these plaintiffs to take up a lawsuit against these giants of the pharmaceutical industry, they were able to do it with the help of legal funding companies.
Thanks to lawsuit loan companies like DeltaSettlementFunding.com, plaintiffs in the Xarelto class-action lawsuit were awarded a substantial settlement. But before we delve deeper into the Xarelto lawsuit details, let us first remind you of how Xarelto entered the market, what its function was, how it allegedly caused injury to patients, and what happened when patients took the makers of Xarelto to court.
What Was The Designed Function Of Xarelto
Xarelto was the name given to an anticoagulant drug developed by Janssen Pharmaceuticals (Johnson & Johnson) and Bayer Corporation called Rivaroxaban. This drug was designed to help reduce the possibility of Stroke, Blood Clots, and Atrial Fibrillation (among other) after surgery by thinning out the blood. It was approved by the FDA in 2011.
What Were The Alleged Side-Effects And Reactions To Xarelto
As soon as Xarelto entered the market and started to be used by hospitals, alleged side effects began to be reported by patients and medical staff. The main reported side effect caused by Xarelto was uncontrolled bleeding (both internal and external), as well as wound leakage, infection, hemorrhagic strokes or brain bleeds. The FDA Adverse Event Reporting System stated in 2017 that of the 22,000 blood-thinner related injuries in the US, Xarelto accounted for 15,043 or them – which included 3018 deaths.
Why Plaintiffs Decided To Take Legal Action
Patients and family members decided to take up a lawsuit against the developers of Xarelto claiming that they failed to warn of the bleeding risks. According to the data, Xarelto has a narrow therapeutic index which means there is a fine line between a safe amount and a dangerous one. In 2018, a drug appeared designed to counteract the effects of Xarelto. In 2018 a “Xarelto antidote” called Andexxa entered the market, but thewholesale cost was over $27,000.
How The Pharmaceutical Companies Responded
Janssen Pharmaceuticals and Bayer Corporation responded to the mounting legal pressures by denying that there were no warnings presented of risks of heavy bleeding. However, the manufacturers claimed that the drug’s label mentioned these risks more than 70 times. Due to this fact, Janssen Pharmaceuticals and Bayer Corporation felt confident that they would be successful in court.
How The Lawsuit Against Xarelto Grew
Plaintiffs originally tried to fight Janssen Pharmaceuticals and Bayer Corporation in court one case at a time. The first trial started in April of 2017 with a 75-year-old plaintiff named Joseph Boudreaux who suffered gastrointestinal bleeding, but the judge ruled in favor of the defense. The next five trials against Xarelto were also ruled in favor of the drug manufacturers. However, this was just the beginning – cases against the drug makers continued to emerge. By April 2019, there were 23,866 lawsuits against Xarelto still pending. Because of this mounting pressure, Janssen Pharmaceuticals and Bayer Corporation offered a settlement to the plaintiffs in March of 2019.
How Janssen Pharmaceuticals and Bayer Corporation Settled The Xarelto Issue
Janssen Pharmaceuticals and Bayer Corporation agreed to pay a settlement of $775 Million Dollars to the plaintiffs in March 2019. The payments varied in amount from case to case, and the terms of the settlement stated Bayer and Janssen did not admit any liability and continued to stand by the drug. Regardless, many Plaintiffs were happy to find some relief after the pain and injuries they suffered.
How Xarelto Plaintiffs Weere Helped By Lawsuit Loans
After the injuries patients suffered due to Xarelto, the ability to apply for lawsuit loans provided some relief and helped them in their fight against the manufacturers as well as in coping with everyday bills. Having suffered from a wide variety of issues such as internal and excessive bleeding, blood clots, and even brain hemorrhages, the quality of life of these plaintiffs was seriously affected. Lawsuit loans meant that at least they won’t have to worry about the financial aspect of the lawsuit.
Lawsuit Loans Helped With Xarelto Plaintiff’s Medical Bills
Due to their serious afflictions in the majority of cases, the plaintiffs were forced to seek further medical treatment. This treatment would include the further administration of prescription drugs, monitored stays in the hospital, etc. The additional medical costs had quite an impact on the financial stability of the plaintiffs. After all, let us keep in mind that the a dose of Andexxa (the Xarelto antidote drug) isn’t cheap at all. On top of that, we also shouldn’t forget that these plaintiffs also faced the costs of their original medical treatment (where they were first given Xarelto). After applying to some of the best lawsuit loan companies in the country, these plaintiffs were able to see a degree of financial relief.
Plaintiffs Were Able To Afford Legal Council With Lawsuit Loans
Many plaintiffs could not afford to seek legal representation in the hopes of pursing a lawsuit against the pharmaceutical giants Johnson & Johnson and Bayer. However, the economic pressures of retaining legal council was significantly reduced once they received their lawsuit loans. With their legal worries taken care of, the Plaintiffs had more time and energy to focus on their health and the health of their family members suffering the alleged side- effects of Xarelto in their bloodstream.
There Were Other Areas Of Financial Strain On Xarelto Plaintiffs
One of the other ways in which financial strain was inflicted upon Xarelto plaintiffs was that over 50% of them stated they were not medically well enough to return to their place of employment due to the side-effects caused by Xarelto. Without a continual steady income, Lawsuit Loans were used to bridge the economic gap until a judgement was reached.
Xarelto May Not Have Settled If Not For Lawsuit Loans
Lawsuits are already costly as it is, and when we take into consideration the medical bills and hindered employment, the burden becomes even heavier. The legal teams representing Xarelto were well aware of this fact and used it to their advantage, often stretching the legal process out as long as possible in order to financially suffocate the plaintiffs.
Thanks to lawsuit loans, that financial pressure was taken off of their shoulders. They were able to pay for the legal fees and continue their battle for justice. With their financial needs taken care of, the Plaintiffs were able to focus on their lawsuits against Xarelto manufacturers. This led to a point where Johnson & Johnson and Bayer were unable to ignore their presence any longer and caused the pharmaceutical titans to offer a substantial settlement of $750,000,000. One might argue that without the help of Lawsuit Loans, Xarelto plaintiffs would not have been able to receive their multi-million dollar settlement.
If you are currently involved in legal troubles and would like to experience the same benefits settlement loans can bring, please don’t hesitate to Apply To Delta Settlement Funding Today. We provide litigious funding for a wide array of cases, not just class-action lawsuits.